Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Orthocell Ltd (AU:OCC)
ASX:OCC
Holding AU:OCC?
Track your performance easily
OCC Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.32 - AU$0.48
Previous CloseAU$0.45
Volume24.32K
Average Volume (3M)178.26K
Market Cap
AU$92.24M
Enterprise ValueAU$82.75M
Total Cash (Recent Filing)AU$11.02M
Total Debt (Recent Filing)AU$507.56K
Price to Earnings (P/E)―
Beta0.82
Next Earnings
Mar 04, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares OutstandingN/A
10 Day Avg. Volume351,261
30 Day Avg. Volume178,263
Standard Deviation0.14
R-Squared0.15
Alpha0.00218
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)48.64
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Orthocell Ltd News
PremiumCompany Announcements
Orthocell Withdraws Revenue Projections
PremiumCompany Announcements
Orthocell Ltd Breaks Into Canadian Market
PremiumCompany Announcements
Orthocell Embraces Corporate Governance Transparency
PremiumCompany Announcements
Orthocell Reinforces Corporate Governance Structure
PremiumCompany Announcements
Orthocell Ltd Reports Strong Revenue Growth Amid Losses
PremiumCompany Announcements
Orthocell Ltd Unveils Investment Opportunity
PremiumCompany Announcements
Orthocell Ltd Issues New Employee Incentive Securities
PremiumCompany Announcements
Orthocell Ltd Announces New Employee Share PlanOptions Prices
Currently, No data available
---
Ownership Overview
8.35% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
91.65% Public Companies and
Individual Investors
OCC FAQ
What was Orthocell Ltd’s price range in the past 12 months?
Orthocell Ltd lowest share price was AU$0.32 and its highest was AU$0.48 in the past 12 months.
What is Orthocell Ltd’s market cap?
Currently, no data Available
When is Orthocell Ltd’s upcoming earnings report date?
Orthocell Ltd’s upcoming earnings report date is Mar 04, 2025 which is in 165 days.
How were Orthocell Ltd’s earnings last quarter?
Orthocell Ltd released its earnings results on Aug 30, 2024. The company reported -AU$0.009 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.009.
Is Orthocell Ltd overvalued?
According to Wall Street analysts Orthocell Ltd’s price is currently Overvalued.
Does Orthocell Ltd pay dividends?
Orthocell Ltd does not currently pay dividends.
What is Orthocell Ltd’s EPS estimate?
Orthocell Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Orthocell Ltd have?
Orthocell Ltd has 209,576,810 shares outstanding.
What happened to Orthocell Ltd’s price movement after its last earnings report?
Orthocell Ltd reported an EPS of -AU$0.009 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5.556%.
Which hedge fund is a major shareholder of Orthocell Ltd?
Currently, no hedge funds are holding shares in AU:OCC
---
Orthocell Ltd Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
18.66%
12-Months-Change
Fundamentals
Return on Equity
-134.46%
Trailing 12-Months
Asset Growth
-10.10%
Trailing 12-Months
Company Description
Orthocell Ltd
Orthocell Ltd is a regenerative medicine company. The company is engaged in the development and commercialisation of cell therapies and related technologies. Its product includes CelGro is a naturally derived collagen medical device for tissue repair and Ortho-ATI is a first-in-class cell therapy for the treatment of chronic tendon injuries.
---
OCC Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Aroa Biosurgery Ltd
―
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
―
Invex Therapeutics Ltd.
―
PainChek Ltd
―
Best Analysts Covering OCC
1 Year
1 Year Success Rate
5/5 ratings generated profit
1 Year Average Return
+19.04%
reiterated a buy rating 3 months ago
Copying Tanushree Jain's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +19.04% per trade.
---